FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 13.05

Change

-0.12 (-0.91)%

Market Cap

CAD 0.05B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.02 (+0.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.03 (+0.06%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.90%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

+0.02 (+0.10%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.40 (+1.12%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.40%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.88% 38% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.88% 38% F 34% F
Trailing 12 Months  
Capital Gain 7.23% 21% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.23% 21% F 24% F
Trailing 5 Years  
Capital Gain 23.00% 44% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.00% 44% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 3.75% N/A N/A 51% F
Dividend Return 4.04% N/A N/A 47% F
Total Return 0.29% N/A N/A 24% F
Risk Return Profile  
Volatility (Standard Deviation) 4.93% N/A N/A 94% A
Risk Adjusted Return 81.98% N/A N/A 91% A-
Market Capitalization 0.05B 46% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.